Clinical Trial Data and the “Do no harm” principle

In an era of evidence based medicine clinical trials hold the key to validate or negate a medical intervention, whatsoever is its nature. However, clinical trials have been under increased scrutiny in the recent past due to concerns over violations of ethical concerns and research related injury. Thus it has become imperative on the part of those at the helm of affairs of clinical trials (drug makers as well as non-governmental organisations and governments which funds such studies) to make available the full and complete information of clinical trial available in public domain.

Making clinical trial data available right from the initial phase’s right till its end in the public domain not only enhances the transparency and validity of the trial it is also beneficial to those running the trial itself. It helps to improve the quality of clinical trials by making it possible to identify potential problems as well as allow health care practitioners to identify researchers related to their field.

Read Dr. Soumyadeep B’s response to the BMJ Open Data Campaign at the British Medical Journal (Open Access)

Advertisements

One thought on “Clinical Trial Data and the “Do no harm” principle

  1. Dr M Chandrashekhar MD says:

    There is scam everywhere ! There are Independent Ethics Committees formed by Doctors’ cartel which approve Clinical Trials . The same Group is part of Ethics Committees of various Hospitals–it is a Package deal– Chairman, Legal guy, Social Workers, Psychologists, Lay Person etc.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s